-
On October 10, 2025, President Donald Trump announced a deal with AstraZeneca to lower drug prices for Medicaid patients by matching the lowest prices in developed countries. The agreement includes AstraZeneca's commitment to invest $50 billion in U.S. manufacturing by 2030 and participation in the upcoming TrumpRx website, which will sell discounted drugs directly to consumers starting in early 2026.
-
On November 13, 2025, Pennsylvania Senator John Fetterman suffered a a ventricular fibrillation flare-up during a morning walk in Braddock, causing him to fall and sustain minor facial injuries requiring 20 stitches. He was hospitalized in Pittsburgh for observation and medication adjustment. Fetterman, 56, has a history of stroke and heart conditions and has been open about his mental health struggles.
-
As of December 2025, the WHO has issued its first guidelines recommending long-term use of GLP-1 medications like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government has negotiated significant price cuts for these drugs, expanding Medicare and Medicaid coverage to more patients. However, concerns remain about drug accessibility, side effects, and weight regain after stopping treatment.